Cingulate Therapeutics Culture | Comparably

Cingulate Therapeutics Unternehmenskultur

Cingulate Therapeutics Culture

Diese Punktzahl ergibt sich aus den Bewertungen und Beurteilungen der Mitarbeiter

Höchstbewertete Kulturdimensionen

N/A

Cingulate Therapeutics CEO

Shane Schaffer Cingulate Therapeutics' CEO
Shane Schaffer

Unternehmensinformation

Adresse
6 South Street
Morristown, NJ
United States of America
Webseite
cingulatetherapeutics.com
Gegründet
2012

Unternehmen Beschreibung

Their unique combination of cutting-edge delivery technology and proven medications will create an unmatched release profile.

Führungspositionen

Name & Titel
Biographie
Shane Schaffer  CEO / President
Shane Schaffer
CEO / President
Shane Schaffer serves as the CEO / President of Cingulate Therapeutics.
Laurie Myers  Member of the Board of Directors
Laurie Myers
Member of the Board of Directors
Laurie Myers serves as the Member of the Board of Directors of Cingulate Therapeutics. Laurie started at Cingulate Therapeutics in June of 2013. Laurie is currently based in the Greater New York City Area.
Craig Tashjy  Vice President of Business Development and Investor Relations
Craig Tashjy
Vice President of Business Development and Investor Relations
Craig Tashjy serves as the Vice President of Business Development and Investor Relations of Cingulate Therapeutics. Craig started at Cingulate Therapeutics in May of 2016. Craig is currently based in the Greater New York City Area.
Lou Horn  Chief Financial Officer
Lou Horn
Chief Financial Officer
Lou Horn serves as the Chief Financial Officer of Cingulate Therapeutics. Lou started at Cingulate Therapeutics in June of 2017. Lou is currently based in the Kansas City, Missouri Area.
Matthew Brams  Chief Medical Officer
Matthew Brams
Chief Medical Officer
Matthew Brams serves as the Chief Medical Officer of Cingulate Therapeutics. Matthew started at Cingulate Therapeutics in January of 2014. Matthew is currently based in the Houston, Texas Area.
Stephen Abele  VP Manufacturing and Development
Stephen Abele
VP Manufacturing and Development
Stephen Abele serves as the VP Manufacturing and Development of Cingulate Therapeutics. Stephen started at Cingulate Therapeutics in January of 2018. Stephen is currently based in the Greater New York City Area.
Ryan Schultz  VP Business Development
Ryan Schultz
VP Business Development
Ryan Schultz serves as the VP Business Development of Cingulate Therapeutics. Ryan started at Cingulate Therapeutics in March of 2016. Ryan is currently based in the Kansas City, Missouri Area.
Holly Mitzel  Vice President, Clinical Operations and Regulatory Affairs
Holly Mitzel
Vice President, Clinical Operations and Regulatory Affairs
Holly Mitzel serves as the Vice President, Clinical Operations and Regulatory Affairs of Cingulate Therapeutics.

Lassen Sie Cingulate Therapeutics wissen, dass Sie dort arbeiten möchten

Sagen Sie Cingulate Therapeutics, dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt Cingulate Therapeutics die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.

Gleichberechtigungs Bewertung Wie positiv bewerten Frauen ihre Gesamterfahrung mit Cingulate Therapeutics

N/A

Herkunftsvielfalts Bewertung Wie positiv bewerten Minderheiten ihre Gesamterfahrung mit Cingulate Therapeutics

N/A

Kennen Sie jemanden, der bei Cingulate Therapeutics arbeitet?

Senden Sie ihnen eine Einladung, um die Unternehmenskultur zu bewerten.

Anonym Einladung versenden

×
Bewerten Sie Ihr Unternehmen